Icotyde Advances Toward European Approval
Europe’s medicines committee recommended Icotyde, or icotrokinra, for adults and adolescents aged 12 years and older weighing at least 40 kilograms with moderate-to-severe plaque psoriasis. The July 24 opinion covers a once-daily oral peptide…
